BioSpace News Archive

SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, today announced final follow-up data for its Phase 1/2 study of GPS in patients with acute myeloid leukemia (AML) in second complete remission (CR2).

Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) (“Cryoport”), the world’s leading temperature-controlled logistics company dedicated to the life sciences industry, today announced a multi-year agreement with Inception Fertility, LLC

Feb. 26, 2020 13:30 UTC Magenta Therapeutics to Participate in Cowen Health Care Conference on Monday, March 2 nd in Boston CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced that the company is scheduled to participate in a fireside chat at the 40 th annual Cowen Health Care Conference on Monday, March 2nd, 20

Feb. 26, 2020 13:30 UTC –The cohort of Eversense ® CGM users will also test modified sensor chemistry.– GERMANTOWN, Md.--( BUSINESS WIRE )-- Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system – the Eversense ® CGM System – today announced the FDA approved a subgroup (with a modified chemistry to enhance longevi

- Distinguished Career at the U.S. Food and Drug Administration in CDER and the Office of Women’s Health; Significant Industry and Regulatory Expertise -

Concord Technologies, a leading provider of cloud-based fax and intelligent document automation software for healthcare providers and enterprises in other regulated industries, announced today the appointment of Christopher Larkin as Chief Technology Officer (CTO)

Chiesi’s CSR program increases contributions to the Triangle community and therapeutic areas

Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that CEO, Brent Vaughan, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference with executives from Akili Interactive Labs, Click Therapeutics and Pear Therapeutics

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar Raythatha, CEO, will present a company overview at the Cowen Health Care Conference in Boston at 1:30 PM EST on Monday, March 2, 2020

LucidHealth, a physician-owned and led radiology company, announced that it is using an AI-powered diagnostic aid from leading AI vendor Aidoc to help prioritize and expedite treatment to patients with critical, life-threatening conditions.